| Identification | Back Directory | [Name]
6-fluoro-3-(4-(3-Methoxy-4-(4-Methyl-1H-iMidazol-1-yl)phenyl)-1H-1,2,3-triazol-1-yl)-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one | [CAS]
1093978-67-6 | [Synonyms]
6-fluoro-3-(4-(3-Methoxy-4-(4-Methyl-1H-iMidazol-1-yl)phenyl)-1H-1,2,3-triazol-1-yl)-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one
2H-1-Benzazepin-2-one, 6-fluoro-1,3,4,5-tetrahydro-3-[4-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-1H-1,2,3-triazol-1-yl]- | [Molecular Formula]
C23H21FN6O2 | [MDL Number]
MFCD18642782 | [MOL File]
1093978-67-6.mol | [Molecular Weight]
432.45 |
| Hazard Information | Back Directory | [Uses]
6-Fluoro-3-(4-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-1H-1,2,3-triazol-1-yl)-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one is a for treating Alzheimer''s disease and related conditions. |
|
| Company Name: |
SPIRO PHARMA
|
| Tel: |
|
| Website: |
www.spiropharma.com.cn |
|